This Plain Language Summary Publication from Neurodegenerative Disease Management looks at the evidence supporting the role of the amyloid-β (Aβ) pathway, how the pathway is not regulated in Alzheimer’s disease (AD), and highlights the reasons why drugs target the Aβ pathway in the early stages of the disease.

Read the full article here. 

The original article on which this Plain Language Summary of Publication is based is titled ‘The Amyloid-β Pathway in Alzheimer’s Disease’ and was published in Molecular Psychiatry. Read the original article here.